138099-41-9

Upstream product

• 849409-73-0 ethyl 3-{bis[(3-chloropropyl)sulfonyl]amino}benzoate 
• 279678-01-2 methyl 3-(1,1-dioxo-isothiazolidin-2-yl)benzoate 

Downstream Products

• 849409-75-2 3-(1,1-dioxo-1,6-isothiazolidin-2-yl)-N-{(1S)-3-methyl-1-[(2R,4R)-4-methyl-5-oxotetrahydro-2-furanyl]butyl}benzamide 
• 1017240-64-0 C₂₉H₄₀N₄O₅S 

Relevant academic research and scientific papers

NOVEL SULFONE AMIDE DERIVATIVES CAPABLE OF INHIBITING BACE

The present invention relates to novel derivatives of sulfone amide of Formula 1 as defined in this disclosure which inhibit the activity of BACE (or beta-secretase). These sulfone amide derivatives are useful for the treatment and prevention of Alzheimer's disease and related diseases caused by production of beta-amyloid, by inhibiting the activity of BACE.

3-(1,1-DIOXOTETRAHYDRO-1,2-THIAZIN-2-YL) or 3-(1,1-DOXO-ISOTHIAZOLIDIN-2YL) SUBSTITUTED BENZAMIDE COMPOUNDS AS ASP2 INHIBITORS

The present invention relates to hydroxyethylene compounds of formula (I); having A sp2 (β-secretase, BACE1 or Memapsin) inhibitory activity, processes for their preparation, to compositions containing them and to their use in the treatment of diseases characterized by elevated β-amyloid levels or β-amyloid deposits, particularly Alzheimer's disease wherein R1 represents a group of formula Zc.